About the Authors
- Yumei Wang
-
Affiliation 5th Medical Department, Section of Endocrinology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany
- Sjoerd Landheer
-
Affiliation Departments of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- Wiek H. van Gilst
-
Affiliation Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- Aart van Amerongen
-
Affiliation Food and Biobased Research, Wageningen University and Research Center, Wageningen, The Netherlands
- Hans-Peter Hammes
-
Affiliation 5th Medical Department, Section of Endocrinology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany
- Robert H. Henning
-
Affiliation Departments of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- Leo E. Deelman
-
Affiliation Departments of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- Hendrik Buikema
-
* E-mail: j.h.buikema@umcg.nl
Affiliation Departments of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Competing Interests
Newtricious BV, Oirlo, was a funder for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: WG AA LD HB. Performed the experiments: YW SL LD HB. Analyzed the data: YW SL RH LD HB. Contributed reagents/materials/analysis tools: YW SL AA RH LD HB. Wrote the paper: YW WG HPH LD HB.